180 related articles for article (PubMed ID: 28267785)
1. Smad3-dependent CCN2 mediates fibronectin expression in human skin dermal fibroblasts.
Purohit T; Qin Z; Quan C; Lin Z; Quan T
PLoS One; 2017; 12(3):e0173191. PubMed ID: 28267785
[TBL] [Abstract][Full Text] [Related]
2. Reduced expression of connective tissue growth factor (CTGF/CCN2) mediates collagen loss in chronologically aged human skin.
Quan T; Shao Y; He T; Voorhees JJ; Fisher GJ
J Invest Dermatol; 2010 Feb; 130(2):415-24. PubMed ID: 19641518
[TBL] [Abstract][Full Text] [Related]
3. Connective tissue growth factor/CCN2-null mouse embryonic fibroblasts retain intact transforming growth factor-beta responsiveness.
Mori Y; Hinchcliff M; Wu M; Warner-Blankenship M; M Lyons K; Varga J
Exp Cell Res; 2008 Mar; 314(5):1094-104. PubMed ID: 18201696
[TBL] [Abstract][Full Text] [Related]
4. Reduction of fibroblast size/mechanical force down-regulates TGF-β type II receptor: implications for human skin aging.
Fisher GJ; Shao Y; He T; Qin Z; Perry D; Voorhees JJ; Quan T
Aging Cell; 2016 Feb; 15(1):67-76. PubMed ID: 26780887
[TBL] [Abstract][Full Text] [Related]
5. Amphiregulin induces CCN2 and fibronectin expression by TGF-β through EGFR-dependent pathway in lung epithelial cells.
Cheng WH; Kao SY; Chen CL; Yuliani FS; Lin LY; Lin CH; Chen BC
Respir Res; 2022 Dec; 23(1):381. PubMed ID: 36578010
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of connective tissue growth factor/CCN2 expression in human dermal fibroblasts by interleukin-1alpha and beta.
Nowinski D; Koskela A; Kiwanuka E; Boström M; Gerdin B; Ivarsson M
J Cell Biochem; 2010 Aug; 110(5):1226-33. PubMed ID: 20544797
[TBL] [Abstract][Full Text] [Related]
7. Requirement for active glycogen synthase kinase-3β in TGF-β1 upregulation of connective tissue growth factor (CCN2/CTGF) levels in human gingival fibroblasts.
Bahammam M; Black SA; Sume SS; Assaggaf MA; Faibish M; Trackman PC
Am J Physiol Cell Physiol; 2013 Sep; 305(6):C581-90. PubMed ID: 23824844
[TBL] [Abstract][Full Text] [Related]
8. CCN3 (NOV) is a negative regulator of CCN2 (CTGF) and a novel endogenous inhibitor of the fibrotic pathway in an in vitro model of renal disease.
Riser BL; Najmabadi F; Perbal B; Peterson DR; Rambow JA; Riser ML; Sukowski E; Yeger H; Riser SC
Am J Pathol; 2009 May; 174(5):1725-34. PubMed ID: 19359517
[TBL] [Abstract][Full Text] [Related]
9. Role of hypoxia in skeletal muscle fibrosis: Synergism between hypoxia and TGF-β signaling upregulates CCN2/CTGF expression specifically in muscle fibers.
Valle-Tenney R; Rebolledo DL; Lipson KE; Brandan E
Matrix Biol; 2020 May; 87():48-65. PubMed ID: 31669521
[TBL] [Abstract][Full Text] [Related]
10. Constitutively activated dystrophic muscle fibroblasts show a paradoxical response to TGF-beta and CTGF/CCN2.
Mezzano V; Cabrera D; Vial C; Brandan E
J Cell Commun Signal; 2007 Dec; 1(3-4):205-17. PubMed ID: 18600480
[TBL] [Abstract][Full Text] [Related]
11. Connective tissue growth factor (CTGF/CCN2) is a downstream mediator for TGF-beta1-induced extracellular matrix production in osteoblasts.
Arnott JA; Nuglozeh E; Rico MC; Arango-Hisijara I; Odgren PR; Safadi FF; Popoff SN
J Cell Physiol; 2007 Mar; 210(3):843-52. PubMed ID: 17133352
[TBL] [Abstract][Full Text] [Related]
12. CCN2 is required for the TGF-β induced activation of Smad1-Erk1/2 signaling network.
Nakerakanti SS; Bujor AM; Trojanowska M
PLoS One; 2011; 6(7):e21911. PubMed ID: 21760921
[TBL] [Abstract][Full Text] [Related]
13. A soluble factor from Trypanosoma cruzi inhibits transforming growth factor-ß-induced MAP kinase activation and gene expression in dermal fibroblasts.
Mott GA; Costales JA; Burleigh BA
PLoS One; 2011; 6(9):e23482. PubMed ID: 21931601
[TBL] [Abstract][Full Text] [Related]
14. Denervation-induced skeletal muscle fibrosis is mediated by CTGF/CCN2 independently of TGF-β.
Rebolledo DL; González D; Faundez-Contreras J; Contreras O; Vio CP; Murphy-Ullrich JE; Lipson KE; Brandan E
Matrix Biol; 2019 Sep; 82():20-37. PubMed ID: 30716392
[TBL] [Abstract][Full Text] [Related]
15. Connective tissue growth factor (CTGF/CCN2) in hepatic fibrosis.
Rachfal AW; Brigstock DR
Hepatol Res; 2003 May; 26(1):1-9. PubMed ID: 12787797
[TBL] [Abstract][Full Text] [Related]
16. Ets-1 is essential for connective tissue growth factor (CTGF/CCN2) induction by TGF-β1 in osteoblasts.
Geisinger MT; Astaiza R; Butler T; Popoff SN; Planey SL; Arnott JA
PLoS One; 2012; 7(4):e35258. PubMed ID: 22539964
[TBL] [Abstract][Full Text] [Related]
17. TGF-beta1-induced connective tissue growth factor (CCN2) expression in human renal proximal tubule epithelial cells requires Ras/MEK/ERK and Smad signalling.
Phanish MK; Wahab NA; Hendry BM; Dockrell ME
Nephron Exp Nephrol; 2005; 100(4):e156-65. PubMed ID: 15855807
[TBL] [Abstract][Full Text] [Related]
18. Differential effects of TGF-beta on connective tissue growth factor (CTGF/CCN2) expression in hepatic stellate cells and hepatocytes.
Gressner OA; Lahme B; Demirci I; Gressner AM; Weiskirchen R
J Hepatol; 2007 Nov; 47(5):699-710. PubMed ID: 17629588
[TBL] [Abstract][Full Text] [Related]
19. Decorin-An Antagonist of TGF-β in Astrocytes of the Optic Nerve.
Schneider M; Dillinger AE; Ohlmann A; Iozzo RV; Fuchshofer R
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299278
[TBL] [Abstract][Full Text] [Related]
20. Temporal and spatial expression of connective tissue growth factor (CCN2; CTGF) and transforming growth factor beta type 1 (TGF-beta1) at the utero-placental interface during early pregnancy in the pig.
Moussad EE; Rageh MA; Wilson AK; Geisert RD; Brigstock DR
Mol Pathol; 2002 Jun; 55(3):186-92. PubMed ID: 12032230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
